Evolent Health, Inc.
Company Information
Industry
Services-Management Services
SIC Code
8741
Entity Type
operating
SEC Category
Large accelerated filer
State of Incorporation
DE
Business Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
Mailing Address
1812 NORTH MOORE ST, SUITE 1705, ARLINGTON, VA, 22209
Phone
571-389-6000
Fiscal Year End
1231
EIN
320454912
Financial Overview
FY2025
$1.60M
Net Income
$1.48B
Total Liabilities
$1.07B
Stockholders' Equity
$151.86M
Cash & Equivalents
$-0.06
EPS
Recent SEC Filings
| Form Type | Date Filed | Document |
|---|---|---|
| SCHEDULE 13G/A Passive ownership amendment | March 26, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 4 Insider stock transaction report | March 4, 2026 | View on SEC |
| 10-K Annual financial report | February 25, 2026 | View on SEC |
| 8-K Current report of material events | February 24, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 13, 2026 | View on SEC |
| SCHEDULE 13G/A Passive ownership amendment | February 11, 2026 | View on SEC |
Material Events
8-K
Acquisition
December 8, 2025
High Impact
- Evolent Health, Inc. completed an acquisition through its subsidiary, Evolent Health LLC.
- The acquisition involved closing transactions from a previously announced Stock Purchase Agreement with Privia Management Company, LLC.
Related Companies
Companies in the same industry (SIC: 8741)
Investor Resources
Learn more about SEC filings and how to research public companies.
What is the SEC?
A plain English guide to the Securities and Exchange Commission
Understanding SEC Filings & CIK
How to navigate SEC filings and Central Index Keys
10-K Annual Reports Explained
Everything you need to know about annual reports
S-1 & F-1 IPO Filings
Understanding IPO registration statements
SEC EDGAR Database Guide
How to use the SEC's free filing database
Important Disclaimer
This AI-generated analysis is for informational purposes only and does not constitute financial or investment advice. Always consult with qualified professionals and conduct your own research before making investment decisions.